RAAS Inhibitors and Risk of Covid-19
N Engl J Med
.
2020 Nov 12;383(20):1991-1992.
doi: 10.1056/NEJMc2030446.
Epub 2020 Oct 27.
Authors
Krishna Sriram
1
,
Rohit Loomba
1
,
Paul A Insel
1
Affiliation
1
University of California San Diego, La Jolla, CA pinsel@health.ucsd.edu.
PMID:
33108103
DOI:
10.1056/NEJMc2030446
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections* / epidemiology
Humans
Pandemics*
Pneumonia, Viral* / epidemiology
Renin-Angiotensin System
SARS-CoV-2